Featured

Areva T&D gets contract worth 35 million Euro from Bhilai Steel Plant

Areva T&D India LimitedAreva T&D India Limited, the Indian subsidiary of AREVA France SA, has bagged a contract worth 35 million euro from Bhilai Steel Plant (BSP)1, a flagship unit of the “Steel Authority of India Ltd” (SAIL), the largest steel manufacturer in India.

This contract includes a 132kV Gas insulated substation and Air insulated substations.

In addition, it also includes the complete revamping of the existing protection & control system and feeding the new sub stations through 132KV transmission cables.

Faster than a bullet - Britons plan a 1,000 miles-an-hour car

London - The British team that already holds the world land speed record said Thursday it plans to build a 1,000-miles-an-hour (1,600 kilometres) car in the next three years.

The Bloodhound SSC (supersonic car) will be 13 metres long, six metres wide and be powered by a jet engine normally used on the Eurofighter, plus a rocket, said project leader Richard Noble.

"We have to defend our record," said Noble, whose team in 1997 produced the current record-holder which reached a speed of 1,228 kilometres (785 miles) an hour, breaking the sound barrier.

Noble said the new car would be faster than a bullet, covering the distance of four football fields in a second.

Karur Vysya Bank signs MoU with ICRA

Karur Vysya BankKarur Vysya Bank has informed that it has signed a

Lung Cancer Linked To 26-New Genes

A study carried out by researchers from the Broad Institute of Massachusetts Institute of Technology and Harvard University have discovered 26-new genes that are linked to the development of lung cancer.

Looking at 188-patient donated samples of lung adenocarcinoma, a very common and deadly form of lung cancer, 623-different genes were studied as possible suspects, and then compared to genes in healthy tissue in patients.  The researchers found that a total of 26-genes were linked to this type of lung cancer that affects 40% of the 1-million lung cancer deaths each year.

Genzyme’s Campath Slows Multiple Sclerosis

A recent study published in The New England Journal of Medicine, reports that Campath, a Genzyme (GENZ) drug already approved for leukemia, could be one of the most effective treatments for multiple sclerosis, as it shows potential for reversing the disease.  Researchers found patients on Campath recovered lost motor functions somewhat and, seemed less disabled three years after trial participation.  The study results suggest that Campath allows damaged nerve tissue to repair.

Banking groups weather financial turmoil according to Q3 reports

Stockholm - Main Swedish banking groups Nordea, Swedbank and SEB on Thursday reported third-quarter results suggesting they had weathered the first phases of the financial turmoil.

Shares for all three groups were mid-morning in positive territory on the Stockholm bourse where the OMXS index was flat. The fourth major group Handelsbanken, which reported Wednesday, was also up.

Banking group Swedbank said its third-quarter operating profit was 3.1 billion kronor (395 million dollars), down 15 per cent year-on-year, while total income in the quarter was 8.2 billion kronor or 13 per cent lower than in second-quarter 2008.

Pages